UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Associate Professor Anish Patel, M.D., recently sat down with UAB MedCast podcast to talk about the telehealth and diabetes.

UAB Comprehensive Diabetes Center Member and Division of Pediatric Endocrinology & Diabetes Assistant Professor Jessica Schmitt, M.D., recently sat down with UAB MedCast podcast to talk about treating pediatric patients with Type 1 diabetes.

Congressman Gary Palmer (AL-06) toured the UAB Comprehensive Diabetes Center (UCDC) on Wednesday, September 4, to learn more about the state of diabetes in Alabama.

Justin Alexander is the Lab Manager and a Researcher in Dr. Sushant Bhatnagar’s lab. He recieved his undergraduate degree from Auburn University. Previously, Alexander gained experience with several types of exocytotic pathways and metabolic disorders in animals while conducting field-based research in Australia and Costa Rica. Alexander’s curiosity about diabetes research grew. Fueled by his interest in exotic animals and plants, he continued to explore the complex chemical machinery driving vesicle fusion.

UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Assistant Professor Fernando Bril, M.D., recently sat down with UAB MedCast podcast to talk about metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes.

UAB Division of Endocrinology, Diabetes, and Metabolism Associate Professor and Scientist in the Comprehensive Diabetes Center Sushant Bhatnagar, Ph.D., was awarded a prestigious one-year R56 grant from the National Institutes of Health (NIH).

Sasanka Ramanadham, Ph.D., and collaborators, published an article entitled “Differential lipid signaling from CD4+ and CD8+ T cells contributes to Type 1 (T1D) diabetes development” in the peer-reviewed journal Frontiers in Immunology.

The scientific journal Frontiers in Endocrinology just published a peer-reviewed perspective article by UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., entitled “A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging”. Other authors from the Shalev Lab include Gu Jing, Ph.D., and SeongHo Jo, Ph.D.

Ananda Basu, M.D., and researchers recently studied the difference in post-prandial glucose turnover between adolescents and adults with Type 1 diabetes (T1D).

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., recently presented at the prestigious 2024 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium (Levine-Riggs Symposium), held in Pasadena, CA, which is organized by City of Hope^®, one of the leading research centers for diabetes and other life-threatening illnesses.